The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
INSMED INC | COM PAR $.01 | 457669307 | 9,032 | 772,240 | SH | DFND | 1 | 772,240 | 0 | 0 | |
OVASCIENCE INC | COM | 69014Q101 | 30,807 | 2,392,034 | SH | DFND | 1 | 2,392,034 | 0 | 0 | |
VERASTEM INC | COM | 92337C104 | 27,694 | 1,995,237 | SH | DFND | 1 | 1,995,237 | 0 | 0 |